Business
Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook
NJBIZ Power List Tevogen named in the NJBIZ Business Power List WARREN, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that it has been named to the 2025 New Jersey Power List by NJBIZ, recognizing the most influential organizations shaping New Jersey’s economic and innovation landscape. NJBIZ highlighted Tevogen’s pioneering ExacTcell™ platform, its advancing pipeline in infectious diseases, oncology, and neurology, and
About this update from Tevogen Bio Holdings Inc.
[{"type":"image","alt":"Tevogen Bio Inc","displaySize":"","headline":null,"caption":"Tevogen Bio Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kuP3e9ZLQ.FWmrA1GfPG6w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f","width":300,"height":157}},"lazy":false},{"type":"text","content":"NJBIZ Power List","length":16,"tagName":"p"},{"type":"image","alt":"Tevogen named in the NJBIZ Business Power List","displaySize":"","headline":null,"caption":"Tevogen named in the NJBIZ Business Power List","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":628,"url":"https://media.zenfs.com/en/globenewswire.com/f2aad63d1721b3c9656a072fb6e55b6e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/S5K2ywWfiqBmnBI5llE.NA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f2aad63d1721b3c9656a072fb6e55b6e","width":960,"height":502},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/X175kIvqxPqENR4gqLeDiw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMjU2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/f2aad63d1721b3c9656a072fb6e55b6e","width":1200,"height":628}}},{"type":"text","content":"WARREN, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that it has been named to the 2025 New Jersey Power List by NJBIZ, recognizing the most influential organizations shaping New Jersey’s economic and innovation landscape.","length":300,"tagName":"p"},{"type":"text","content":"NJBIZ highlighted Tevogen’s pioneering ExacTcell™ platform, its advancing pipeline in infectious diseases, oncology, and neurology, and the Company’s internally developed PredicTcell™ AI technology, designed to accelerate target prediction and improve clinical outcomes. The publication also mentioned Tevogen’s previously projected near-term commercial potential, including an anticipated ~$1 billion in first-year specialty-care revenue and a cumulative five-year forecast of $18–22 billion.","length":493,"tagName":"p"},{"type":"text","content":"Tevogen was further recognized fo...